Insulin is thought to be an important regulator of leptin secretion. However, increasing evidence suggests that insulin-mediated glucose uptake rather than insulin per se regulates circulating leptin concentration. Here, we hypothesised that a reduction of insulin sensitivity, ie insulin resistance, will diminish the stimulatory effect of insulin on leptin secretion as a consequence of decreased insulin-mediated glucose uptake. DESIGN: Changes in serum leptin concentration during 30 hyperinsulinaemic -hypoglycaemic clamps were studied after induction of different levels of insulin resistance in normal-weight men. In 15 subjects insulin sensitivity was reduced by exposing them to a 2.5 h antecedent hypoglycaemia (3.1 mmol=l) induced by a high rate of insulin infusion (15.0 mU=min=kg) on the day before the proper experiment ('ante-hypo' condition). In the other 15 subjects no antecedent hypoglycaemia was induced ('control' condition). The proper experiment on both conditions was a 6 h stepwise hypoglycaemic clamp induced by a constant rate of insulin infusion (1.5 mU=min=kg). SUBJECTS: Experiments were carried out in 30 lean healthy subjects (age, mean AE s.e.m., 26 AE 1 y; body mass index, 23.1 AE 0.6 kg=m 2 ). RESULTS: As expected, glucose demand during the clamp was lower in the ante-hypo condition than in the control condition (gram of glucose infused per kilogram body weight, 1.52 AE 0.16 vs 2.01 AE 0.17 g=kg; P < 0.05). During the clamp, leptin levels increased by 25.4 AE 4.3% in the control condition (P < 0.05), but not in the ante-hypo condition ( þ 4.8 AE 4.5%; P > 0.25). Thus, serum leptin response to the clamp significantly differed between the two conditions (P < 0.01). Across both conditions, the increase of leptin levels during the clamp was correlated with the amount of glucose infused (r ¼ 0.37; P < 0.05). CONCLUSION: Considering that insulin concentrations were identical during both clamp conditions, the data indicate that experimentally-induced insulin resistance diminishes the stimulatory effect of insulin on leptin secretion.
Introduction
Leptin, the ob-gene product, is considered an important hormone of energy balance. Predominantly expressed in adipose tissue, it acts as an afferent signal to the brain, informing the hypothalamus about fat stores. 1 Accumulating evidence suggests that insulin is a potent regulator of plasma leptin concentration. First, a correlation between plasma insulin and leptin concentration has been found in several cross-sectional studies independent of body adiposity. 2 -5 Second, insulin stimulates ob-gene expression in cultured adipocytes. 6, 7 Third, leptin levels have been found to increase during hyperinsulinaemic -euglycaemic clamp experiments. 8 -10 Moreover, Saad et al 11 showed that insulin increases plasma leptin concentration in a dose-dependent manner by performing euglycaemic clamp experiments with different degrees of insulinaemia. Notably, using the same rate of insulin infusion, during hypoglycaemic clamps the rise of leptin was found to be attenuated as compared to euglycaemic clamps. 12 This finding suggests that insulinmediated glucose uptake rather than insulin per se may regulate leptin secretion. This view is also supported by in vitro data showing that blockade of glucose transport inhibits leptin secretion from adipocytes 13 and that the hexosamine biosynthetic pathway probably represents the responsible mechanism whereby intracellular glucose regulates leptin expression and secretion. 14 The extent of insulin-mediated glucose uptake mainly depends on three factors: first, the degree of insulinaemia; second, the availability of glucose (euglycaemia vs hypoglycaemia); and third, the degree of insulin sensitivity. Insulinaemia 11 and glycaemia 12 have been varied in previous studies to investigate the effects of insulin and glucose on leptin secretion. In a recent work, 15 we varied both insulinaemia and glycaemia and found that the rise of leptin levels closely paralleled the cumulative amount of glucose infused during euglycaemic and hypoglycaemic clamps with differing degrees of hyperinsulinaemia.
In the present study, we assessed the influence of insulin sensitivity on the stimulatory effects of insulin on leptin secretion. Insulin sensitivity was systematically manipulated by exposing lean healthy subjects to antecedent hypoglycaemia and hyperinsulinaemia, both of which are known to induce insulin resistance. 16, 17 Changes in serum leptin concentration were assessed during a subsequent 6 h hyperinsulinaemic -hypoglycaemic clamp induced by a constant rate of insulin infusion. According to the hypothesis, we expected the rise in leptin concentration during insulin infusion to be diminished after induction of insulin resistance and also that the changes in leptin concentration during the clamp would be related to the amount of glucose infused. In addition, in the present study we evaluated the relationship between changes in leptin levels and the neuroendocrine hypoglycaemic counter-regulation.
Methods

Subjects
Experiments were carried out in 30 lean healthy men (age, mean AE s.e.m., 26 AE 1 y; body mass index (BMI), 23.1 AE 0.6 kg=m 2 ). Exclusion criteria were chronic or acute illness, current medication of any kind, smoking, alcohol or drug abuse, and diabetes or hypertension in first-degree relatives. Each volunteer gave written informed consent and the study was approved by the local ethics committee.
Study design
Leptin levels were measured at 30 min intervals during a total of 30 hyperinsulinaemic -hypoglycaemic clamps lasting 6 h. Since hypoglycaemia as well as hyperinsulimaemia are known to subsequently reduce insulin sensitivity, 16 ,17 15 subjects were subjected to a 2.5 h hypoglycaemic clamp induced by a high rate of insulin infusion (15.0 mU=min= kg) preceding the proper experiment in order to reduce insulin sensitivity ('ante-hypo' condition). The other 15 subjects were tested without an antecedent hypoglycaemia ('control' condition).
Antecedent hypoglycaemic clamp
On the day preceding the proper 6 h hyperinsulinaemichypoglycaemic clamp, the subjects reported to the medical research unit at 13:30. All subjects were instructed not to have breakfast and to abstain from eating until the end of the clamp. The experiments took place in a sound-attenuated room with the subjects sitting with their trunk in an almost upright position (about 60
) and their legs in a horizontal position on the bed. A cannula was inserted into a vein on the back of the hand, which was placed in a heated box (50 -55 C) to obtain arterialised venous blood. A second cannula was inserted into an antecubital vein of the contralateral arm. Both cannulas were connected to long thin tubes, which enabled blood sampling and adjustment of the rate of glucose infusion from an adjacent room without the subject's awareness. At 14:00 infusion of insulin (Hinsulin, Hoechst, Frankfurt, Germany) was started at a constant rate of 15.0 mU=min=kg. Plasma glucose levels were measured (Beckman Glucose Analyser, Munich, Germany) every 5 min and a variable infusion of 20% glucose solution was adjusted so that a constant plasma glucose level at approximately 3.1 mmol=l was maintained.
Hyperinsulinaemic -hypoglycaemic clamp
On the day of the 6 h hyperinsulinaemic -hypoglycaemic clamp experiment, all subjects reported to the medical research unit at 8:00 after an overnight fast of at least 10 h. The setting of these hyperinsulinaemic -hypoglycaemic clamps was the same as those of the ante-hypo. After a 1 h baseline period, insulin was infused at a continuous rate of 1.5 mU=min=kg for the following 6 h. Arterialized blood was drawn at 5 min intervals to measure plasma glucose concentration. A 20% glucose solution was simultaneously infused at a variable rate to control plasma glucose levels. Plasma glucose levels were reduced in a stepwise manner to achieve four respective plateaus of approximately 4.2, 3.7, 3.2 and 2.7 mmol=l. Each plateau was maintained for a 45 min period and the next lower plateau was induced gradually within the next 45 min. Blood samples for determination of plasma or serum levels of insulin, leptin, C-peptide, and counterregulatory hormones were collected every 30 min.
Analytical methods
All blood samples were immediately centrifuged and the supernatants stored at 7 24 C until assay. Serum leptin was measured by RIA (Linco, St Louis, MO, USA) with an interassay CV of 6.1% and an intra-assay CV of 5.4%. Serum C-peptide was measured by RIA (C-Peptide-RIA, Hermann Biermann Diagnostica, Bad Nauheim, Germany) with an interassay CV < 3.2%, an intra-assay CV < 5.6%. Serum insulin, cortisol, growth hormone, glucagon and plasma ACTH, adrenaline and noradrenaline were measured as previously described. 18 Insulin and serum leptin concentration B Fruehwald-Schultes et al
Statistical methods
All values are presented as means AE s.e.m. Values for all variables were averaged across the baseline period. The BMI of all subjects was estimated by dividing the body weight (in kilograms) by the square of the height (in metres). Because of a great inter-individual variability in baseline leptin levels, changes in leptin during the clamp were expressed as difference values with reference to the baseline value (averaged across baseline) divided by the baseline value (D leptin %). Changes in counter-regulatory hormones during the clamp were determined by subtracting the respective baseline value. Data analysis was based on analysis of variance for repeated measures including the factors 'time' (duration of the clamp) and 'condition' (ante-hypo vs control). The interaction term of both factors indicated differences between conditions in the leptin response to the clamp. Unpaired Student's t-test were used to compare values at baseline and at the different points in time during the clamp between the experimental conditions. Pearson's correlation coefficients were calculated and multiple linear regression analysis was performed to assess associations between the variables. A P-value < 0.05 was considered statistically significant.
Results
Antecedent hypoglycaemic clamp
During the antecedent hypoglycaemic clamp, plasma glucose concentrations decreased to approximately 3.1 mmol=l within the first 30 min and then maintain this level for the next 2 h (data not shown). Mean serum insulin concentration during the clamp was 21 618 AE 1854 pmol=l.
Baseline values before starting the hyperinsulinaemichypoglycaemic clamp During the baseline period, serum levels of insulin (61.8 AE 4.2 vs 46.2 AE 3.6 pmol=l; P < 0.01) and C-peptide (0.71 AE 0.04 vs 0.50 AE 0.04 nmol=l; P < 0.005) as well as plasma glucose levels (5.6 AE 0.1 vs 5.1 AE 0.1 mmol=l; P < 0.01) were distinctly higher in the ante-hypo condition than in the control condition. Also, baseline serum leptin levels were higher in the ante-hypo than control condition (4.11 AE 0.59 vs 3.20 AE 0.51 ng=ml), but the difference did not reach significance (P ¼ 0.28). This difference in baseline leptin levels were most likely explained by the higher BMI in the subjects of the ante-hypo condition (23.7 AE 0.7 vs 22.5 AE 0.5 kg=m 2 ), although this difference did also not reach significance (P ¼ 0.15). Across both conditions, baseline serum leptin levels were correlated with the BMI (r ¼ 0.63; P < 0.001) and baseline levels of serum insulin (r ¼ 0.59; P < 0.001), serum C-peptide (r ¼ 0.35; P ¼ 0.06), and plasma glucose (r ¼ 0.41; P < 0.05). Multiple regression analysis revealed that serum leptin concentration was independently related to the BMI (P < 0.005) and to serum insulin concentration (P < 0.005), together accounting for 55% of the variance in leptin levels (r 2 ¼ 0.55). No correlations were observed between baseline leptin and ACTH, cortisol, growth hormone, glucagon, adrenaline and noradrenaline levels.
Hyperinsulinaemic -hypoglycaemic clamp
During the hyperinsulinaemic -hypoglycaemic clamp, the decrease in plasma glucose level was highly comparable in both conditions ( Figure 1A) . After starting the insulin infusion, serum insulin levels rapidly increased to approximately 570 mmol=l in both conditions and then maintained this level for the rest of the clamp ( Figure 1B ). There were no differences in serum insulin levels between the two conditions throughout the clamp. In contrast, the total amount of glucose (per kilogram body weight) infused during the clamp was significantly lower in the ante-hypo condition than in the control condition (1.52 AE 0.16 vs 2.01 AE 0.17 g=kg; P < 0.05), indicating a difference in glucose demand to achieve similar levels of glycaemia. Glucose requirement, reflected by glucose infusion rates, was markedly lower in the ante-hypo than control condition during the first half of the clamp (Figure 2A) , while during the last two hypo- Insulin and serum leptin concentration B Fruehwald-Schultes et al glycaemic plateaus of the clamp differences in infusion rates did not reach significance (Table 1) . Due to baseline differences, absolute levels of serum leptin did not significantly differ between the two conditions throughout the clamp ( Figure 2B ). However, the response of serum leptin concentration to the clamp distinctly differed between the two conditions (P < 0.01 for the 'condition by time' interaction term). While in the control condition serum leptin levels increased by 25.4 AE 4.3% (P < 0.05), serum leptin levels in the ante-hypo condition were not significantly changed in the end of the clamp ( þ 4.8 AE 4.5%; P > 0.25; Figure 2C ). Separate analysis of the different hypoglycaemic plateaus revealed that the relative changes in serum leptin levels during the clamp started to significantly differ between the two conditions at the second plateau (Table 1) . While in the control condition serum leptin levels increased by 3.8 AE 1.8% between the first and second hypoglycaemic plateau (P ¼ 0.05), serum leptin levels in the ante-hypo condition decreased by 5.5 AE 1.4% during the same time interval (P < 0.01 for the decrease; P < 0.001 for comparison between conditions). After this decline, serum leptin concentration in the ante-hypo condition increased by 9.0 AE 4.4% until the end of the clamp (P ¼ 0.07). During the same time interval, ie from the second to fourth plateau, serum leptin concentration increased by 14.8 AE 3.5% in the control condition (P < 0.001). The difference between the two conditions in the rise in leptin levels during this time interval did not reach significance (P ¼ 0.14).
Across both conditions, changes in leptin (D leptin %) achieved in the end of the clamp were positively correlated with the total amount of glucose infused during the clamp (r ¼ 0.37; P < 0.05; Figure 3A) . Furthermore, there was a positive correlation between the increase in leptin levels in the end of the clamp (D leptin % at 360 min) and the amount of glucose infused during the first 180 min of the clamp (r ¼ 0.54; P < 0.001; Figure 3B ), suggesting that the amount of glucose infused within the first half of the clamp interval predicted the increase in leptin level achieved in the end of the clamp period.
Relationships between changes in leptin levels during the clamp and the neuroendocrine counter-regulatory response to hypoglycaemia were determined for the pooled data of both conditions. The changes in leptin in the end of the clamp were inversely correlated with the counter-regulatory increase of serum cortisol (r ¼ 7 0.38; P < 0.05). There was no such correlation with changes in ACTH, growth hormone, glucagon, adrenaline and noradrenaline.
Discussion
In the present study, insulin sensitivity was systemically manipulated by exposing lean healthy subjects to an antecedent hypoglycaemia in association with hyperinsulinaemia. Compared to the control condition, the antecedent hypoglycaemia resulted in higher baseline levels of serum insulin and C-peptide as well as plasma glucose. Moreover, to Data are presented as mean AE s.e.m.. *P < 0.05; } P < 0.005; { P < 0.001 for comparison between the ante-hypo and control condition by unpaired Student's t-test.
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Leptin levels increased during the hyperinsulinaemichypoglycaemic clamp experiments, which is in line with previous data. 12, 15 However, the increase was blunted in the ante-hypo condition, in which glucose demand and insulin sensitivity were reduced. Interestingly, a transitory decrease in leptin levels during the first half of the clamp in the ante-hypo condition largely accounted for the difference in the leptin response to the clamp between the two experimental conditions. This transitory decrease in leptin levels can most likely be explained by the previous observed 11 diurnal changes in leptin levels in combination with a strongly reduced stimulatory effect of insulin due to insulin resistance. Noteworthy, during the first half of the clamp glucose requirement in the ante-hypo condition was distinctly lower than in the control condition, indicating that insulin resistance was most pronounced during the time interval. During the second half of the clamp, glucose requirements as well as changes in leptin levels did not significantly differ between the two conditions, which may be explained by a decreasing difference in insulin sensitivity between both conditions. Taken together, the present results show for the first time that the stimulatory effect of insulin on leptin secretion is diminished after induction of insulin resistance.
Changes in serum leptin levels were positively correlated with the amount of glucose infused during the clamp suggesting that leptin levels, at least in part, depended on the amount of glucose infused. However, the found correlation was weaker than expected. Therefore, it must be pointed out that the present study does not allow a clear cut conclusion about the mechanism whereby induced insulin resistance diminished the stimulatory effects of insulin on leptin secretion. Although the data suggest that the mechanism could have been the reduced insulin-mediated glucose uptake, results may also be consistent with insulin resistance blocking a direct insulin signalling pathway that is independent of intracellular glucose.
The present finding is in line with previous observations by Saad et al 11 that the stimulatory effects of insulin on leptin diminishes with decreasing insulin sensitivity. Also, leptin synthesis has been found resistant to acute effects of insulin in type 1 diabetic patients. 19 Importantly, in this study glucose disposal rates during hyperinsulinaemiceuglycaemic clamps were significantly lower in the type 1 diabetic patients than in healthy controls (47.6 AE 2.3 vs 66.2 AE 28 mmol=kg min; P < 0.01) in spite of identical rates of insulin infusion. This pattern indicates that the type 1 diabetic patients were less sensitive to the stimulatory effects of insulin on glucose uptake. Consequently, reduced insulin sensitivity and glucose uptake could explain the lack of changes in leptin secretion in these patients. Moreover, differences in insulin sensitivity could explain the results of several cross-sectional studies 20 -23 where serum leptin levels did not differ between type 2 diabetic patients and healthy controls in spite of the well-known hyperinsulinism in type 2 diabetes. Since insulin resistance is a common feature of type 2 diabetes, 24 high insulin levels in these patients are presumably not associated with an increased stimulation of leptin secretion, which would explain the unchanged leptin levels.
Factors others than insulin sensitivity and glucose uptake, however, could also have modulated serum leptin levels in the present study. It has been shown that glucocorticoids increase 7,25 -27 and catecholamines decrease 28, 29 leptin secretion. However, in the present study, differences in the leptin response to insulin infusion between conditions mainly occurred between the first and second hypoglycaemic plateau, ie when plasma glucose levels were still above the Insulin and serum leptin concentration B Fruehwald-Schultes et al threshold for counter-regulatory hormone release. 30 Therefore, it is unlikely that counter-regulatory hormones have confounded present results.
Interestingly, changes in leptin levels during the clamp were inversely correlated with the counter-regulatory cortisol response to hypoglycaemia. One explanation for this finding may be an inhibitory effect of leptin on the hypothalamic -pituitary -adrenal (HPA) axis. This view is supported by previous studies, suggesting a distinct inhibitory action of leptin on the secretory activity of the central 31 -34 as well as adrenal 35 site of the axis. In conclusion, the present study shows that the stimulatory influence of insulin on circulating leptin concentration depends on the degree of insulin sensitivity. This finding may explain the previous observed unchanged serum leptin levels in hyperinsulinaemic subjects, such as patients with type 2 diabetes.
